PLATELET REFRACTORINESS

Clinical trials for PLATELET REFRACTORINESS explained in plain language.

Never miss a new study

Get alerted when new PLATELET REFRACTORINESS trials appear

Sign up with your email to follow new studies for PLATELET REFRACTORINESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New hope for cancer patients with unstoppable bleeding

Disease control Terminated

This study tested whether giving a concentrated clotting protein called fibrinogen could help stop severe bleeding in cancer patients whose bodies don't respond to standard platelet transfusions. The trial focused on patients with blood cancers undergoing intensive chemotherapy w…

Matched conditions: PLATELET REFRACTORINESS

Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

PLATELET REFRACTORINESS

Get alerted when new PLATELET REFRACTORINESS trials appear

New hope for cancer patients with unstoppable bleeding